MedTrace Logo

CLassification of Axial SpondyloarthritiS Inception Cohort

NCT03993847 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 501

Last updated 2022-12-08

No results posted yet for this study

Summary

A joint meeting of the ASAS (Assessment of Spondyloarthritis Internal Society) and SPARTAN (Spondyloarthritis Research and Treatment Network) executive boards recommended that the existing ASAS classification criteria for spondyloarthritis undergo further validation.

SPARTAN is in charge of conducting a a prospective study of a North American cohort of patients presenting with undiagnosed active chronic back pain to rheumatologists in the US and Canada, and one site in Mexico.

ASAS is in charge of conducting a similar study in Europe and other parts of the world.

Conditions

  • Spondyloarthritis

Sponsors & Collaborators

  • AbbVie

    collaborator INDUSTRY

  • Amgen

    collaborator INDUSTRY

  • Janssen Scientific Affairs, LLC

    collaborator INDUSTRY

  • Eli Lilly and Company

    collaborator INDUSTRY

  • Novartis Pharmaceuticals

    collaborator INDUSTRY

  • Pfizer

    collaborator INDUSTRY

  • UCB Pharma

    collaborator INDUSTRY

  • Spondyloarthritis Research and Treatment Network

    lead NETWORK

Principal Investigators

  • Walter P Maksymoywch, MD · Spondyloarthritis Research and Treatment Network

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-04
Primary Completion
2022-08-22
Completion
2022-08-22

Countries

  • United States
  • Canada
  • Mexico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03993847 on ClinicalTrials.gov